Results 241 to 250 of about 39,584 (275)
Some of the next articles are maybe not open access.

CMT

2013
openaire   +2 more sources

CMT-COVID Survey

Clinical Medical Case Reports and Reviews, 2022
openaire   +1 more source

CMT

2009
Nils Peters   +199 more
openaire   +1 more source

CMT 73 26021

2021
Ranasinghe, Gerard   +2 more
openaire   +1 more source

CMT

Neurology Today, 2003
openaire   +1 more source

CMT Twin welding-brazing of aluminum to titanium

Welding in the World, Le Soudage Dans Le Monde, 2022
Wanghui Xu, Huan He
exaly  

CMT-3. CollaGenex.

Current opinion in investigational drugs (London, England : 2000), 2004
CMT-3 is an orally active matrix metalloprotease inhibitor, and one of a series of inhibitors of multiple proteases and cytokines, under development by CollaGenex. The compound is currently undergoing phase II trials for the potential treatment of cancer, in particular metastatic cancer and HIV-related Kaposi's sarcoma.
openaire   +1 more source

Home - About - Disclaimer - Privacy